Vanguard Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,877,512
| Closed | -$27.1M | – | 4244 |
|
|
2020
Q3 | $27.1M | Sell |
2,877,512
-206,927
| -7% | -$1.97M | ﹤0.01% | 2311 |
|
|
2020
Q2 | $23.6M | Sell |
3,084,439
-43,911
| -1% | -$336K | ﹤0.01% | 2342 |
|
|
2020
Q1 | $19.3M | Buy |
3,128,350
+301,121
| +11% | +$2.65M | ﹤0.01% | 2302 |
|
|
2019
Q4 | $34.4M | Sell |
2,827,229
-284,090
| -9% | -$3.1M | ﹤0.01% | 2283 |
|
|
2019
Q3 | $35.9M | Buy |
3,111,319
+345,082
| +12% | +$3.63M | ﹤0.01% | 2226 |
|
|
2019
Q2 | $27.6M | Sell |
2,766,237
-990,496
| -26% | -$10.7M | ﹤0.01% | 2363 |
|
|
2019
Q1 | $48.4M | Buy |
3,756,733
+398,274
| +12% | +$5.93M | ﹤0.01% | 2100 |
|
|
2018
Q4 | $51M | Buy |
3,358,459
+76,605
| +2% | +$1.46M | ﹤0.01% | 2016 |
|
|
2018
Q3 | $65.6M | Buy |
3,281,854
+69,550
| +2% | +$1.58M | ﹤0.01% | 2009 |
|
|
2018
Q2 | $62.6M | Sell |
3,212,304
-76,811
| -2% | -$1.7M | ﹤0.01% | 2013 |
|
|
2018
Q1 | $66.3M | Sell |
3,289,115
-65,405
| -2% | -$1.11M | ﹤0.01% | 1923 |
|
|
2017
Q4 | $44.4M | Buy |
3,354,520
+132,865
| +4% | +$2M | ﹤0.01% | 2121 |
|
|
2017
Q3 | $59.4M | Buy |
3,221,655
+214,231
| +7% | +$3.99M | ﹤0.01% | 1955 |
|
|
2017
Q2 | $55.3M | Sell |
3,007,424
-77,924
| -3% | -$1.54M | ﹤0.01% | 1970 |
|
|
2017
Q1 | $69.6M | Buy |
3,085,348
+176,832
| +6% | +$4.23M | ﹤0.01% | 1840 |
|
|
2016
Q4 | $101M | Buy |
2,908,516
+64,611
| +2% | +$1.93M | 0.01% | 1604 |
|
|
2016
Q3 | $69.7M | Buy |
2,843,905
+47,213
| +2% | +$1.18M | ﹤0.01% | 1778 |
|
|
2016
Q2 | $66.9M | Buy |
2,796,692
+62,190
| +2% | +$1.43M | ﹤0.01% | 1766 |
|
|
2016
Q1 | $64M | Buy |
2,734,502
+334,656
| +14% | +$7.94M | ﹤0.01% | 1748 |
|
|
2015
Q4 | $72.5M | Buy |
2,399,846
+95,789
| +4% | +$3.09M | ﹤0.01% | 1686 |
|
|
2015
Q3 | $91.5M | Buy |
2,304,057
+786,527
| +52% | +$48.8M | 0.01% | 1494 |
|
|
2015
Q2 | $105M | Buy |
1,517,530
+540,307
| +55% | +$34M | 0.01% | 1487 |
|
|
2015
Q1 | $53.4M | Buy |
977,223
+250,758
| +35% | +$12M | ﹤0.01% | 1875 |
|
|
2014
Q4 | $31M | Sell |
726,465
-12,946
| -2% | -$468K | ﹤0.01% | 2062 |
|
|
2014
Q3 | $23.6M | Buy |
739,411
+12,253
| +2% | +$261K | ﹤0.01% | 2135 |
|
|
2014
Q2 | $15.1M | Buy |
727,158
+9,075
| +1% | +$168K | ﹤0.01% | 2327 |
|
|
2014
Q1 | $13.9M | Buy |
718,083
+22,036
| +3% | +$468K | ﹤0.01% | 2336 |
|
|
2013
Q4 | $16.9M | Buy |
696,047
+46,826
| +7% | +$1.1M | ﹤0.01% | 2230 |
|
|
2013
Q3 | $13.9M | Buy |
649,221
+29,092
| +5% | +$687K | ﹤0.01% | 2239 |
|
|
2013
Q2 | $13.8M | Buy |
+620,129
| New | +$13.7M | ﹤0.01% | 2201 |
|
Vanguard Group's AMAG Position: Q4 2020 in Review
Vanguard Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,877,512 shares — an estimated $27.1M sold.
Vanguard Group first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $105M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Vanguard Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Vanguard Group sold 2,877,512 AMAG Pharmaceuticals shares in Q4 2020, an estimated $27.1M.
- Vanguard Group first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Vanguard Group's AMAG Pharmaceuticals position peaked at $105M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Vanguard Group's 13F filing for Q4 2020, filed 12 Feb 2021.